Lv1
30 积分 2025-10-13 加入
Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Biological Insights and Therapeutic Opportunities
3小时前
待确认
Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human
3天前
已完结
Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives
1个月前
已关闭
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
1个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
